J&J Exit from Diabetes Seen Positive for (TNDM), (PODD) and (MDT) and Slight Negative for DexCom (DXCM) - Wedbush
Wedbush analyst Tao Levy weighed in on news Johnson & Johnson (NYSE: JNJ) announced that it was considering the divestiture ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)